-- 安徽豊源製薬（SHE:000153）は、同社の複合ポリエチレングリコール・電解質粉末について、中国医薬品規制当局から医薬品登録を取得しました。 深セン証券取引所への金曜日の提出書類によると、この処方粉末は小児の慢性便秘の治療薬として適応されます。 承認の有効期限は2031年4月28日です。 同社の株価は金曜日、1%高で取引を終えました。
Related Articles
Asia
Jefferies Adjusts Tokyo Electron's Price Target to 59,000 Yen From 48,000 Yen, Keeps at Buy
Tokyo Electron (TYO:8035) has an average rating of overweight and mean price target of 51,813.64 yen, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)
$TYO:8035
Asia
Singapore-listed Aspial Corp Buys Back More Shares
Aspial Corp. (SGX:A30) bought back 400,000 shares in the open market on Friday for SG$59,454.According to a same-day filing with the Singapore Exchange, the jewelry and real estate company has bought back 1,150,000 shares since its mandate of daily share repurchases started April 28.
$SGX:A30
Asia
Jefferies Adjusts Blue Star's Price Target to INR1,735 From INR1,665, Keeps at Hold
Blue Star (NSE:BLUESTARCO, BOM:500067) has an average rating of hold and mean price target of 1,836.04 Indian rupees, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)
$BOM:500067$NSE:BLUESTARCO